Tuesday · November 10, 2026

 ·  Daily  ·  Newsletters

Resonance network: Quantum InsiderSpace Insider

Business & Markets · Startups

SeqOne Receives €20M to Expand AI-Driven Genomic Analysis for Oncology and Rare Diseases

Montpellier-based SeqOne, a deeptech company specializing in AI-powered genomic analysis, has announced a €20 million oversubscribed growth funding round led by Supernova Invest, with continued backing from Elaia, Omnes, and Mérieux Equity Partners. The new capital will support SeqOne’s international expansion, U.S. market entry, and platform development as demand for automated, scalable NGS data interpretation accelerates.

CEO Martin Dubuc said the investment reflects confidence in the company’s mission to deliver precision medicine globally. He noted the funds will help scale operations, enhance AI capabilities, and solidify SeqOne’s position as a trusted partner for molecular labs worldwide. The company currently supports 140 labs in 22 countries and expects to process over 110,000 patient analyses in 2025.

James Dargan
About the author
James Dargan

James Dargan is a writer and researcher at The AI Insider. His focus is on the AI startup ecosystem and he writes articles on the space that have a tone accessible to the average reader.

The AI economy, every weekday morning

The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.